On November 14 and 15, 2022, the National Cancer Policy Forum, in collaboration with the Forum on Drug Discovery, Development, and Translation, hosted a public workshop that examined the current challenges related to resistance to immune modulator therapies for cancer and discussed potential policy levers that could help to overcome these challenges.
Planning Committee
Samir N. Khleif, Georgetown University Medical Center (Co-Chair)
George J. Weiner, University of Iowa (Co-Chair)
Gideon Blumenthal, Merck
Chris Boshoff, Pfizer, Inc
Tom Curran, Children’s Mercy, Kansas City
Nancy E. Davidson, Fred Hutchinson Cancer Center and University of Washington
Julie Gralow, American Society of Clinical Oncology
Roy S. Herbst, Yale School of Medicine
Hedvig Hricak, Memorial Sloan Kettering Cancer Center
Scott M. Lippman, University of California, San Diego
Kimryn Rathmell, Vanderbilt University Medical Center
Marc Theoret, Food and Drug Administration
Speakers:
Gideon Blumenthal, Merck
Chris Boshoff, Pfizer Inc
Peter Bross, Food and Drug Administration
Tom Curran, Children’s Mercy Research Institute, Children’s Mercy, Kansas City
Nancy Davidson, Fred Hutchinson Cancer Center
Teresa Davoli, NYU Grossman School of Medicine
Hildegund Ertl, The Wistar Institute
Usama Fayyad, Institute for Artificial Intelligence, Northeastern University
Keith Flaherty, Massachusetts General Hospital; Harvard Medical School
Nicole Gormley, Office of Oncologic Diseases, CDER, Food and Drug Administration
Julie Gralow, American Society of Clinical Oncology
Stephan A. Grupp, The Children’s Hospital of Philadelphia
Jane A. Healy, Merck Research Labs
Roy Herbst, Yale Comprehensive Cancer Center
Jack Hidary, SandboxAQ
Hedvig Hricak, Memorial Sloan Kettering Cancer Center
Elizabeth Jaffee, President’s Cancer Panel; Johns Hopkins University
John Janik, CullinanOncology
Samir N. Khleif, Georgetown University Medical Center
Scott Lippman, University of California, San Diego
Jason Luke, UPMC Hillman Cancer Center
Marius Mayerhoefer, Memorial Sloan Kettering Cancer Center
Dana Pe'er, Memorial Sloan Kettering Cancer Center
Reena Philip, Oncology Center of Excellence, Food and Drug Administration
Kimryn Rathmell, Vanderbilt University Medical Center
Elad Sharon, Cancer Therapy Evaluation Program, NCI
Alexandra Snyder, Generate Biomedicines
Hussein Tawbi, MD Anderson Cancer Center
Ahmad Tarhini, Moffitt Cancer Center
Marc Theoret, Oncology Center of Excellence, Food and Drug Administration
Suzanne Louise Topalian, Johns Hopkins
George Weiner, Holden Comprehensive Cancer Center
Jedd Wolchok, Weill Cornell Medicine
Prakirthi Yerram, Flatiron Health